Trimodal Tx may benefit some bladder Ca patients.

Bibliographic Details
Published in:Urology Times Vol. 46; no. 3; pp. 8 - 10
Main Author: Bowser, Andrew D.
Format: Journal Article
Published: MJH Life Sciences Mar2018
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128592143&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128592143
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Mar2018
      vid: 46
      iid: 3
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        128592143
        128592143
      ppf: 8
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Trimodal Tx may benefit some bladder Ca patients.
      aug:
        au: Bowser, Andrew D.
      sug:
        subj:
          Bladder Neoplasms Therapy
          Combined Modality Therapy
          Cancer Patients
          Cystectomy Methods
          Bladder Neoplasms Prognosis
          Treatment Outcomes
          Bladder Neoplasms Mortality
          Survival
          Lymphatic Diseases Risk Factors
          Lymph Node Excision
          Endoscopy
          Chemoradiotherapy
          Mortality Risk Factors
          Comorbidity
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N